Australian Institute of Health and Welfare (2021) Alcohol and other drug treatment services in Australia annual report., AIHW, Australian Government, accessed 28 January 2022
Australian Institute of Health and Welfare. (2021). Alcohol and other drug treatment services in Australia annual report. Retrieved from https://pp.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Alcohol and other drug treatment services in Australia annual report. Australian Institute of Health and Welfare, 16 July 2021, https://pp.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Australian Institute of Health and Welfare. Alcohol and other drug treatment services in Australia annual report [Internet]. Canberra: Australian Institute of Health and Welfare, 2021 [cited 2022 Jan. 28]. Available from: https://pp.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Australian Institute of Health and Welfare (AIHW) 2021, Alcohol and other drug treatment services in Australia annual report, viewed 28 January 2022, https://pp.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia
Get citations as an Endnote file:
On this page:
In 2019–20, 104 publicly funded alcohol and other drug treatment agencies in Western Australia provided 25,090 closed treatment episodes to 19,133 clients (tables SA.1, SCR.21).
Western Australia reported:
The visualisation shows that 25,090 closed treatment episodes were provided to an estimated 19,133 clients in Western Australia in 2019–20. This equates to a rate of 1,094 episodes and 835 clients per 100,000 population, a higher rate than the 1,064 episodes and 624 clients per 100,000 population nationally.
In 2019–20, most (86%) clients in Western Australia attended 1 agency, and received an average of 1.3 closed treatment episodes, which is lower than the national average of 1.7 treatment episodes (tables SCR.21, SCR.23).
The visualisation includes a series of horizontal bar graphs showing that, in 2019–20, over 9 in 10 (92%) clients in Western Australia received treatment for their own drug use. Of these clients, around two-thirds (65%) were male, 57% were aged 20–39, and 24% were Indigenous Australians. Nearly all clients (98%) listed English as their preferred language and most (84%) were born in Australia.
Over the period 2015–16 to 2019–20, 67,882 clients received treatment in Western Australia. Of these clients:
In 2019–20, for clients in Western Australia receiving treatment episodes for their own alcohol or drug use:
Clients can nominate up to 5 additional drugs of concern; these drugs are not necessarily the subject of any treatment within the episode (see Technical notes).
In 2019–20, when the client reported additional drugs of concern:
Over the period 2015–16 to 2019–20:
The grouped horizontal bar chart shows that, in 2019–20, amphetamines and alcohol were the most common principal drugs of concern in treatment episodes provided to clients in Western Australia for their own drug use (both 34%). This was followed by cannabis (21%) and heroin (5.5%). Cannabis was the most common additional drug of concern (23% of episodes), followed by alcohol (16%) and nicotine (15%).
The line graph shows that, between 2015–16 and 2019–20, methamphetamine has remained the most common drug of concern among meth/amphetamine-related treatment episodes for clients’ own drug use. The proportion of methamphetamine-related episodes increased from 76% in 2015–16 to 92% in 2019–20. Conversely, there was a decrease in the proportion of episodes relating to amphetamines (from 19% to 7.1%).
The stacked horizontal bar chart shows the method of use for treatment episodes related to clients’ own use of meth/amphetamines in Western Australia in 2019–20. Injecting and smoking were the first and second most common methods of use, respectively, for treatment episodes relating to amphetamine (59% for injecting and 34% for smoking) and methamphetamine (55% and 43%, respectively). All episodes for other amphetamines as the principal drug of concern listed ingesting as the method of use.
In 2019–20, for treatment episodes in Western Australia:
Western Australia does not differentiate between main and other treatment types.
The grouped horizontal bar chart shows that, in 2019–20, the most common main treatment type provided to clients in Western Australia for their own drug use was counselling (71% of episodes). This was followed by support and case management (6.9%), pharmacotherapy and withdrawal management (6.0% and 5.9% respectively). No additional treatment types were reported.
In 2019–20, in Western Australia:
In the 5 years to 2019–20, the number of publicly funded treatment agencies in Western Australia rose from 79 to 104 (Table SA.1).
The horizontal bar chart shows that most treatment agencies in Western Australia were located in Major cities (65 agencies), followed by Outer regional and Remote areas (12 and 11 agencies respectively). Of the total 104 treatment agencies, most (94 agencies) were non-government agencies.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.